Mirjam Sprangers - Publications#

H-index google scholar (June 10, 2023): 101 (40.949 citations), i10 index: 367.

Selection of recent work related to response shift

1. Sprangers MAG, Sajobi T, Vanier A, Mayo NE, Sawatzky R, Lix LM, Oort FJ, Sébille V, Response Shift—in Sync Working Group. Response shift in results of patient-reported outcome measures: a commentary to The Response Shift-in Sync Working Group initiative. Quality of Life Research, 2021; 30: 3299–3308.

2. Sawatzky R, Kwon J.-Y, Barclay R., Chauhan C, Frank L, van den Hout WB, Kongsgaard-Nielsen L, Nolte S, Sprangers MAG, & the Response Shift – in Sync Working Group. Implications of response shift for micro-, meso-, and macro-level healthcare decision-making using results of patient-reported outcome measures. Quality of Life Research 2021; 30: 3343-3357.

3. Verdam MGE, van Ballegooijen W, Holtmaat CJM, Knoop H, Lancee J, Oort FJ, Riper H, van Straten A, Verdonck-de Leeuw IM, de Wit M, van der Zweerde T, Sprangers MAG. Re-evaluating randomized clinical trials of psychological interventions: Impact of response shift on the interpretation of trial results. PLoS One 2021; 16(5): e0252035.

4. Hartog ID, Willems DL, van den Hout WB, Scherer-Rath M, Oreel TH, Henriques JPS, Nieuwkerk PT, van Laarhoven HWM, Sprangers MAG. Influence of response shift and disposition on patient-reported outcomes may lead to suboptimal medical decisions: a medical ethics perspective. BMC Medical Ethics 2019; 20(1): 61.

Selection of recent clinically applied research

5. Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, Reyners AKL, Russel NS, Schriek M, Sijtsema S, van Tienhoven G, Verdam M, Sprangers MAG. Risk factors of unmet needs among women with breast cancer in the post-treatment phase. Psycho-Oncology 2020; 29(3): 539-549.

6. Noordman BJ, Verdam MGE, Lagarde SM, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch OR, ten Kate FJW, Creemers GJM, Punt CJA, Plukker John ThM, Verheul HMW, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A, Sprangers MAG, van Lanschot JJB. Effect of neoadjuvant chemoradiotherapy on health-related quality of life in esophageal or junctional cancer: Results from the randomized CROSS trial. Journal of Clinical Oncology 2018; 36(3): 268-275.

Selection of recent methodological work

7. Van Kleef JJ, ter Veer EE, van den Boorn HG, Schokker S, Ngai LL, Prins MJ, Mohammed NH, van de Poll- Franse LV, Zwinderman AH, van Oijen MGH, Sprangers MAG, van Laarhoven HWM. Quality of Life during palliative systemic therapy for esophagogastric cancer: Systematic review and meta-analysis. Journal of the National Cancer Institute 2020; 112(1): 12-29.

8. Oreel TH, Borsboom D, Epskamp S, Hartog ID, Netjes JE, Nieuwkerk PT, Henriques JPS, Scherer-Rath M, van Laarhoven HWM, Sprangers MAG. The dynamics in health-related quality of life of patients with stable coronary artery disease were revealed: a network analysis. Journal of Clinical Epidemiology 2019; 107:116-123.

Selection of papers that led to international recognition

9. Sprangers MAG, Schwartz, CE. Integrating response shift into health-related quality of life research: a theoretical model. Social Science & Medicine 1999; 48: 1507-1515.
(2412 citations according to Google Scholar)

10. Sprangers MAG, Groenvold M, Arraras JI, Franklin J, Velde te A, Muller M, Franzini L, Williams A, Haes de JCJM, Hopwood P, Cull A, Aaronson NK on behalf of the EORTC Study Group on Quality of Life. The EORTC breast cancer specific quality of life questionnaire module (QLQ BR23): first results from a three country field study. Journal of Clinical Oncology 1996; 14: 2756-68. (1137 citations according to Google Scholar)

Reprinted and commented in: Classic Papers and Current Comments, 2001; 5: 917-929.